3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
27
Burkitt Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasm Metastasis
4
Leukemia, Biphenotypic, Acute
4
Immunoglobulin Light-chain Amyloidosis
4
Smoldering Multiple Myeloma
3
Down Syndrome
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Lung Neoplasms
2
Hodgkin Disease
2
Breast Neoplasms
2
Brain Neoplasms
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Plasmacytoma
1
Myelodysplastic Syndromes
1
Meningioma
1
Mastocytosis, Systemic
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
venetoclax
69
Cyclophosphamide
53
ibrutinib
45
obinutuzumab
43
acalabrutinib
43
Rituximab
40
fludarabine
37
fludarabine phosphate
30
Specimen Handling
29
pirtobrutinib
26
Biopsy
24
zanubrutinib
23
Whole-Body Irradiation
16
Bendamustine Hydrochloride
15
Magnetic Resonance Spectroscopy
14
Mycophenolic Acid
13
Lenalidomide
11
Peripheral Blood Stem Cell Transplantation
9
Sirolimus
8
idelalisib
7
Tacrolimus
7
CT-P10
7
ARQ531
7
tafasitamab
6
Prednisone
6
Busulfan
6
pembrolizumab
5
Stem Cell Transplantation
5
Melphalan
5
Interleukin-2
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
dexamethasone 21-phosphate
×
1 year
×
Clear all
No trials found.